On the other hand, TWIST1 is shown to enhance the expression of miR-10a in CD34+ cells in myelodysplastic syndrome, and TWIST1/miR-10a-axis could be used as a therapeutic target in the treatment of the myelodysplastic syndrome [138]. Here, CD34 is linked to myelodysplastic syndrome.